Lipase News and Research

RSS
Gene therapy improves chylomicron metabolism in LPLD patients

Gene therapy improves chylomicron metabolism in LPLD patients

Researchers identify human receptor that can taste fat

Researchers identify human receptor that can taste fat

New metabolic pathway for controlling brain inflammation

New metabolic pathway for controlling brain inflammation

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

ATGL produces key signaling molecules essential for regulation of lipid, energy metabolism

ATGL produces key signaling molecules essential for regulation of lipid, energy metabolism

Scientists directly link lipid metabolism and cancer-associated cachexia

Scientists directly link lipid metabolism and cancer-associated cachexia

Glybera gene therapy reduces pancreatitis risk in Lipoprotein Lipase Deficiency patients

Glybera gene therapy reduces pancreatitis risk in Lipoprotein Lipase Deficiency patients

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis

FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis

Abbott’s CREON receives FDA approval for infant-specific dose

Abbott’s CREON receives FDA approval for infant-specific dose

Trimeris, Synageva enter definitive merger agreement

Trimeris, Synageva enter definitive merger agreement

Mayoly-Spindler, ProteaBio complete MS1819 Phase I/IIA trial in malabsorption syndrome

Mayoly-Spindler, ProteaBio complete MS1819 Phase I/IIA trial in malabsorption syndrome

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

Eli Lilly receives FDA complete response letter for liprotamase NDA

Eli Lilly receives FDA complete response letter for liprotamase NDA

Synageva BioPharma closes $25 million private equity financing

Synageva BioPharma closes $25 million private equity financing

Synageva supports Fourth International Rare Disease Day

Synageva supports Fourth International Rare Disease Day

AMT 2010 total net income increases to EUR 1.4 million

AMT 2010 total net income increases to EUR 1.4 million